Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Researchers develop new MRI-based technique to better detect NAFLD in children

Researchers develop new MRI-based technique to better detect NAFLD in children

Chemotherapy or immunosuppressive treatment may reactivate HBV

Chemotherapy or immunosuppressive treatment may reactivate HBV

Can-Fite BioPharma completes patient enrollment in CF101 Phase II/III psoriasis trial

Can-Fite BioPharma completes patient enrollment in CF101 Phase II/III psoriasis trial

International community funding can significantly reduce cancer deaths in LMICs by 2030

International community funding can significantly reduce cancer deaths in LMICs by 2030

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Quest Diagnostics, CDC partner to identify trends in diagnosis and treatment for viral hepatitis

Quest Diagnostics, CDC partner to identify trends in diagnosis and treatment for viral hepatitis

Quest Diagnostics, CDC collaborate to reduce deaths from hepatitis

Quest Diagnostics, CDC collaborate to reduce deaths from hepatitis

Attaching Epirubicin drug to nanodiamonds eliminates chemoresistant cancer stem cells

Attaching Epirubicin drug to nanodiamonds eliminates chemoresistant cancer stem cells

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Researchers examine how terpenes can inhibit growth of liver cancer cells

Researchers examine how terpenes can inhibit growth of liver cancer cells

GenSpera reports encouraging results from mipsagargin Phase II study for HCC treatment

GenSpera reports encouraging results from mipsagargin Phase II study for HCC treatment

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

Researchers develop novel method to predict risk of liver cancer recurrence after transplantation

Researchers develop novel method to predict risk of liver cancer recurrence after transplantation

Can-Fite BioPharma completes RA Phase III study of lead drug candidate CF101

Can-Fite BioPharma completes RA Phase III study of lead drug candidate CF101

EB Pharma licenses tipifarnib from Janssen to study potential new therapy for HDV

EB Pharma licenses tipifarnib from Janssen to study potential new therapy for HDV

Study underscores the importance of appropriate testing, support and care for HCV patients

Study underscores the importance of appropriate testing, support and care for HCV patients

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

New analysis finds global improvements in life expectancy

New analysis finds global improvements in life expectancy

New study highlights importance of generating awareness about HCV testing, support and care

New study highlights importance of generating awareness about HCV testing, support and care

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.